| Health / Medical Topics |
5-Fluorouracil/Salicylic Acid Topical Solution
A topical formulation containing 0.5 % of antimetabolite 5-fluorouracil (5-FU) and 10% of salicylic acid, with potential antimitotic and keratolytic activity. Upon cutaneous application, 5-FU in the 5-fluorouracil/salicylic acid topical solution impedes pyrimidine metabolism thereby inhibiting cell growth, while the salicylic acid induces anti-inflammatory response and results in keratolytic effect. This may result in the breakdown of keratinocytes and prevent proliferation of keratinocytes locally. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat cancers of the breast, stomach, and pancreas, and certain types of colorectal and head and neck…
A fluoronucleoside that inhibits pyrimidine synthesis, interfering with DNA synthesis.
A substance being studied in the treatment of some types of cancer. It may prevent the growth of tumors by stopping cancer…
A radioconjugate consisting of the 7 amino acid peptide sequence ASYNYDA (GI heptapeptide) and labeled with the fluorescent dye fluorescein isothiocyanate (5-FITC),…
A radioconjugate consisting of a 7 amino acid peptide sequence, KCCFPAQ, that specifically targets human colon cancer and that is labeled, via…
5-aminolevulinate synthase, nonspecific, mitochondrial (640 aa, ~71 kDa) is encoded by the human ALAS1 gene. This protein plays a role in both…
